Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia

The myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal myeloid malignancies characterized by multilineage cytopenias, recurrent cytogenetic abnormalities, and risk of progression to acute myeloid leukemia (AML). AML, which can occur de novo as well as secondary to MDS, is chara...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Cogle, Christopher R., Scott, Bart L., Boyd, Thomas, Garcia-Manero, Guillermo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: AlphaMed Press 2015
Pynciau:
Hematologic Malignancies
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679081/
https://ncbi.nlm.nih.gov/pubmed/26463870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0165
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg